Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients
Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients
复制标题
DOI：
10.1016/j.kint.2018.11.038
复制
发表时间：
2019-04-01
影响因子：
19.6
通讯作者：
Pisoni, Ronald L.
中科院分区：
文献类型：
--
作者：
Jadoul, Michel;Bieber, Brian A.;Pisoni, Ronald L.
丙型肝炎病毒感染在透析患者中很常见，并与发病率和死亡率的增加有关。我们使用透析结果和实践模式研究(DOPPS，1996-2015)来评估根据有记录的诊断或抗体阳性定义的丙型肝炎病毒感染的流行率、发病率和危险因素的趋势。在流行的血液透析患者中，2012-2015年间丙型肝炎病毒感染率接近10%。患病率从比利时的4%到中东的20%不等，中国、日本、意大利、西班牙和俄罗斯的患病率居中。在参与DOPPS一个以上阶段的大多数国家中，丙型肝炎病毒感染率随着时间的推移而下降，在最近(
Hepatitis C virus (HCV) infection is common in dialysis patients and is associated with increased morbidity and mortality. We used the Dialysis Outcomes and Practice Patterns Study (DOPPS, 1996-2015) to assess trends in the prevalence, incidence, and risk factors for HCV infection as defined by a documented diagnosis or antibody positivity. Among prevalent hemodialysis patients, HCV prevalence was nearly 10% in 2012-2015. Prevalence ranged from 4% in Belgium to as high as 20% in the Middle East, with intermediate prevalence in China, Japan, Italy, Spain, and Russia. HCV prevalence decreased over time in most countries participating in more than one phase of DOPPS, and prevalence was around 5% among patients who had recently (